Previous close | 2.2000 |
Open | 2.2000 |
Bid | 2.0500 |
Ask | 2.4000 |
Strike | 150.00 |
Expiry date | 2025-01-17 |
Day's range | 2.2000 - 2.2000 |
Contract range | N/A |
Volume | |
Open interest | 4 |
Charles River and Lundbeck sign an agreement to use Logica to advance the discovery of novel neurological drugs.
WILMINGTON, Mass., October 03, 2024--Charles River previews SfN 2024, including the latest developments in CNS research and innovative approaches to tackling neurodegenerative disorders.
WILMINGTON, Mass., October 02, 2024--Charles River and Lundbeck enter agreement to utilize AI-powered Logica to advance the discovery of novel drugs for neurological disease.